Panacea Biotec is an Innovation-driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution, and Marketing of Pharmaceuticals, Vaccines, and Biosimilars.
Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited with a commitment to make Innovative Products Affordable and Accessible to the masses. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd.
Panacea Biotec is witnessing a period of expansion across every aspect of our business from innovative products to customers in the market, from manufacturing to regulatory approvals and thereby laying the foundation for translation of our vision in becoming the greatest, largest, and most admired biotechnology company in the World by 2020.
Ardent Research and Development efforts have always been a great strength of Panacea Biotec. The main research areas are New Chemical Entities (NCE), New Biological Entities (NBE) Novel Drug Delivery System (NDDS) based on pharmaceutical formulations, Novel peptides & human monoclonal antibodies, and Vaccine Development. The company has developed four distinguished, ultra-modern, state-of-art R&D centers in different locations, having internal capabilities for constant research, with over 300 highly professional and skilled scientists engaged in various aspects of research.
Focused research efforts have led to the grant of worldwide product patents valid in over 68 countries for Panacea Biotec. As of 31st March 2011, the company had filed over 1400 patent applications in various parts of the world including India. Of these, 382 have been granted patents and others are under various stages of examination or publication by the patent authorities. Some of these countries are the USA, U.K., France, Germany, Italy, Sweden, Denmark, Spain, Finland, Switzerland, The Netherlands, New Zealand, Mexico, Brazil, Nigeria, Zimbabwe, Australia, South Africa, Japan, Russia, Canada, Ukraine, Korea, and China.
Our aspirations are supported by our Globally accredited USFDA approved manufacturing facility at Baddi supported by the 4 “State-of-the-Art” R&D Centres.
The company has ultra-modern, state-of-art production facilities at Baddi (Himachal Pradesh), Lalru (Punjab) & Delhi for manufacturing tablets, capsules (including soft gelatin), ointments (including transfer formulation) liquids, herbal formulations, and vaccines. The facilities are WHO cGMP compliant among other regulatory bodies such as USFDA, UKMHRA, Saudi FDA, ANVISA, etc.